Catalog No. | Product Name | Summary | Targets | CAS Number | Smiles |
A3220 | Bardoxolone | Once-a-day treatment for CKD | Apoptosis|KEAP1-Nrf2 | 218600-44-3 | CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C |
A4395 | 10-DAB (10-Deacetylbaccatin) | Precursor of antitumor compound Palitaxel and Docetaxel | Cell Cycle/Checkpoint|Microtubule/Tubulin | 32981-86-5 | O[[C@H](C(C)(C)C1=C(C)[[C@H]2O)(C2)[[C@H]([[C@@H]([[C@H@](C([[C@H]1O)=O)(C)[[C@@H]3O)[[C@H]4([[C@@H](C3)OC4)OC(C)=O)OC(C5=CC=CC=C5)=O |
B1839 | Spiramycin | 16-membered ring macrolide (antibiotic) | Lab Reagents|Antibiotics | 8025-81-8 | CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C |
B7556 | Zearalenone | Mycotoxin produced by several species of Fusarium fungi | Endocrinology and Hormones|Estrogen/progestogen Receptor | 17924-92-4 | O=C(CCC/C=C/C1=C2C(O)=CC(O)=C1)CCC[[C@H](C)OC2=O |
C4832 | Maslinic Acid | inhibitor of NO, H2O2 , IL-6 and TNF-α | Apoptosis|TNF-α | 4373-41-5 | CC1(C)CC[[C@H]2(C(O)=O)CC[[C@H@]3(C)[[C@H]4(C)CCC5C(C)(C)[[C@@H](O)[[C@H](O)C[[C@H]5(C)[[C@H@]4([H])CC=C3[[C@H@]2([H])C1 |
N1289 | Vindoline | Monomeric vinca-alkaloid | Natural Products | 2182-14-1 | O=C([[C@H@]1([[C@H]2([H])N(C([H])([H])[H])C3=C(C([H])=C([H])C(OC([H])([H])[H])=C3[H])[[C@H]24[[C@H@](C(C([H])([H])C([H])([H])[H])(C([H])=C([H])C5([H])[H])[[C@H@]1([H])OC(C([H])([H])[H])=O)([H])N5C([H])([H])C4([H])[H])O[H])OC([H])([H])[H] |
N1674 | Piperine | MAPK inhibitor | Natural Products | 94-62-2 | C1CCN(CC1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3 |
N1707 | Coumarin | Precursor in chemical reaction | Natural Products | 91-64-5 | C1=CC=C2C(=C1)C=CC(=O)O2 |